Phase 3 Safety and Efficacy of AZD1222 (CHADOX1 NCoV-19) Covid-19 Vaccine

Falsey, A. R., Sobieszczyk, M. E., Hirsch, I., Sproule, S., Robb, M. L., Corey, L., Neuzil, K. M., Hahn, W., Hunt, J., Mulligan, M. J., McEvoy, C., DeJesus, E., Hassman, M., Little, S. J., Pahud, B. A., Durbin, A., Pickrell, P., Daar, E. S., Bush, L., … Gonzalez-Lopez, A. (2021). Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. New England Journal of Medicine, 385(25), 2348–2360. https://doi.org/10.1056/nejmoa2105290
Authors:
Ann R. Falsey
Magdalena E. Sobieszczyk
Ian Hirsch
Stephanie Sproule
Merlin L. Robb
Lawrence Corey
Kathleen M. Neuzil
William Hahn
Julie Hunt
Mark J. Mulligan
Charlene McEvoy
Edwin DeJesus
Michael Hassman
Susan J. Little
Barbara A. Pahud
Anna Durbin
Paul Pickrell
Eric S. Daar
Larry Bush
Joel Solis
Quito Osuna Carr
Temitope Oyedele
Susan Buchbinder
Jessica Cowden
Sergio L. Vargas
Alfredo Guerreros Benavides
Robert Call
Michael C. Keefer
Beth D. Kirkpatrick
John Pullman
Tina Tong
Margaret Brewinski Isaacs
David Benkeser
Holly E. Janes
Martha C. Nason
Justin A. Green
Elizabeth J. Kelly
Jill Maaske
Nancy Mueller
Kathryn Shoemaker
Therese Takas
Richard P. Marshall
Menelas N. Pangalos
Tonya Villafana
Antonio Gonzalez-Lopez
Affiliated Authors:
Magdalena E. Sobieszczyk
Columbia Affiliation:
elink
Publication Type:
Article
Unique ID:
10.1056/NEJMoa2105290
PMID:
34587382
DOI:
10.1056/NEJMoa2105290
Journal:
New England Journal of Medicine
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: